ONTX - Onconova Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $2997.53. This is a potential upside of $2989.6 (37699.87%) from yesterday's end of day stock price of $7.93.

Onconova Therapeutics's activity chart (see below) currently has 1 price targets and 5 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 22.67 days.

Most recent stock forecast was given by AHU DEMIR from LADENBURG on 01-Mar-2022. First documented stock forecast 20-Feb-2014.

Best performing analysts who are covering ONTX - Onconova Therapeutics:

Ahu Demir Charles Duncan Jason Mccarthy

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

6.9

2 years 1 months 29 days ago

1/2 (50%)

$0.47 (7.31%)

1

Buy

18.75

$10.82 (136.44%)

3 years 11 months 14 days ago

1/1 (100%)

$13.34 (246.58%)

67

Buy

13500

$13499.29 (1901308.50%)

13500

8 years 4 months 22 days ago

0/2 (0%)

$8955 (223.72%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ONTX (Onconova Therapeutics) average time for price targets to be met?

On average it took 22.67 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on ONTX (Onconova Therapeutics) with a proven track record?

AHU DEMIR

Which analyst has the current lower performing score on ONTX (Onconova Therapeutics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on ONTX (Onconova Therapeutics)?

Ahu Demir works at LADENBURG and has 3 price targets and 4 ratings on ONTX

Which analyst is the currently most bullish on ONTX (Onconova Therapeutics)?

Charles Duncan with highest potential upside - $13499.29

Which analyst is the currently most reserved on ONTX (Onconova Therapeutics)?

Ahu Demir with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?